These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8661411

  • 21. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ, Li GH, Fong SE, Nagashima K, Gonda MA.
    Virology; 1997 Sep 29; 236(2):307-15. PubMed ID: 9325238
    [Abstract] [Full Text] [Related]

  • 22. Functional relationship between the matrix proteins of feline and simian immunodeficiency viruses.
    Manrique ML, González SA, Affranchino JL.
    Virology; 2004 Nov 10; 329(1):157-67. PubMed ID: 15476883
    [Abstract] [Full Text] [Related]

  • 23. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.
    Notka F, Stahl-Hennig C, Dittmer U, Wolf H, Wagner R.
    Biol Chem; 1999 Mar 18; 380(3):341-52. PubMed ID: 10223337
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
    Wang BZ, Liu W, Kang SM, Alam M, Huang C, Ye L, Sun Y, Li Y, Kothe DL, Pushko P, Dokland T, Haynes BF, Smith G, Hahn BH, Compans RW.
    J Virol; 2007 Oct 18; 81(20):10869-78. PubMed ID: 17670815
    [Abstract] [Full Text] [Related]

  • 31. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T, Galarza JM.
    J Virol; 2001 Jul 18; 75(13):6154-65. PubMed ID: 11390617
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
    Celma CC, Paladino MG, González SA, Affranchino JL.
    Virology; 2007 Sep 30; 366(2):405-14. PubMed ID: 17559903
    [Abstract] [Full Text] [Related]

  • 34. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
    González SA, Affranchino JL.
    Virology; 1998 Jan 05; 240(1):27-35. PubMed ID: 9448686
    [Abstract] [Full Text] [Related]

  • 35. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
    Bouamr F, Garnier L, Rayne F, Verna A, Rebeyrotte N, Cerutti M, Mamoun RZ.
    Virology; 2000 Dec 20; 278(2):597-609. PubMed ID: 11118382
    [Abstract] [Full Text] [Related]

  • 36. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
    Negri DR, Buffa V, Leone P, Bona R, Borghi M, Carlini F, De Angelis F, Indraccolo S, Ensoli B, Cara A.
    J Immunol Methods; 2004 Aug 20; 291(1-2):153-63. PubMed ID: 15345313
    [Abstract] [Full Text] [Related]

  • 37. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
    Leung NJ, Aldovini A, Young R, Jarvis MA, Smith JM, Meyer D, Anderson DE, Carlos MP, Gardner MB, Torres JV.
    Virology; 2000 Mar 01; 268(1):94-103. PubMed ID: 10683331
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein.
    Manrique JM, Affranchino JL, González SA.
    Virology; 2008 May 10; 374(2):273-9. PubMed ID: 18255119
    [Abstract] [Full Text] [Related]

  • 40. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins.
    Anderson MJ, Porter DC, Moldoveanu Z, Fletcher TM, McPherson S, Morrow CD.
    AIDS Res Hum Retroviruses; 1997 Jan 01; 13(1):53-62. PubMed ID: 8989427
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.